NewsJanuary 8
Announcement of Changes of Corporate Officers at PHC Holdings Corporation Effective March 31, April 1, 2025
Please be advised of the changes in the following Corporate Officers at PHC Holdings Corporation effective March 31, April 1, 2025.
(1) Resignation of Corporate Officer on March 31, 2025
| Position/Title |
Name |
Remarks |
| Corporate Officer |
Robert Schumm |
Head of BGM Business
President, Ascensia Diabetes Care Holdings AG |
(2) Change in Responsibilities of Corporate Officers on April 1, 2025
| Name |
New Responsibility from April 1, 2025 |
Responsibility Until March 31, 2025 |
| Koichiro Sato |
Technology, Manufacturing, Procurement, Risk Management, Corporate Planning, Business Development, Medical Policy & Public Affairs
Head of Diabetes Management Domain,
Head of Healthcare Solutions Domain
Head of BGM Business
President, Ascensia Diabetes Care Holdings AG |
Technology, Manufacturing, Procurement, Risk Management,
Corporate Planning, Business Development, Medical Policy & Public Affairs
Head of Diabetes Management Domain,
Head of Healthcare Solutions Domain |
(3) Corporate Officers at PHC Holdings Corporation on April 1, 2025
| Position/Title |
Name |
Role and Responsibilities |
| Chief Executive Officer (CEO) |
Kyoko Deguchi |
Group Management, Internal Audit |
Chief Operating Officer (COO)
Chief Strategy Officer（CSO） |
Koichiro Sato |
Technology, Manufacturing, Procurement, Risk Management,
Corporate Planning, Business Development, Medical Policy & Public Affairs
Head of Diabetes Management Domain,
Head of Healthcare Solutions Domain
Head of BGM Business
President, Ascensia Diabetes Care Holdings AG |
Senior Executive Corporate Officer
Chief Administrative Officer (CAO)
Chief Human Resources Officer (CHRO)
Chief Transformation Officer (CTO) |
Ryuichi Hirashima |
General Affairs, Human Resources, Legal & Compliance, Intellectual Property, Transformation, Information Technology |
Executive Corporate Officer
Chief Financial Officer (CFO) |
Kaiju Yamaguchi |
Corporate Accounting, Corporate Finance,
Investor Relations, Corporate Communications |
| Executive Corporate Officer |
Nobuaki Nakamura |
Head of Diagnostics & Life Sciences Domain
President, Representative Director, PHC Corporation |
| Corporate Officer |
Steven Lynum |
Deputy Head of Diagnostics & Life Sciences Domain
Head of Pathology Business
President, Epredia Holdings Ltd. |
| Corporate Officer |
Kenichi Uchino |
Head of LSIM Business
President and Chief Executive Officer, LSI Medience Corporation |
| Corporate Officer |
Chikara Takauo |
Head of Biomedical Business
Director, PHC Corporation |
| Corporate Officer |
Hideaki Takahashi |
Head of Healthcare IT Solution Business
President, Representative Director, Wemex Corporation |